Current Neurology

volume 6: this year we emphasize the tremedous progress in neuromuscular diseases including the application of recombinant DNA technology to Duchenne muscular distrophy and myotonic muscular dystrophy, and the application of immunlogical technique to myasthenia gravis and myasthenic syndrome.